메뉴 건너뛰기




Volumn 26, Issue 1, 2006, Pages 90-96

Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance

(25)  Tanaka, Eiji a   Matsumoto, Akihiro a   Suzuki, Fumitaka b   Kobayashi, Mariko b   Mizokami, Masashi c   Tanaka, Yasuhito c   Okanoue, Takeshi d   Minami, Masahito d   Chayama, Kazuaki e   Imamura, Michio e   Yatsuhashi, Hiroshi f   Nagaoka, Shinya f   Yotsuyanagi, Hiroshi g   Kawata, Sumio h   Kimura, Tatsuji i   Maki, Noboru i   Iino, Shiro j   Kiyosawa, Kendo a   Yasuda, Kiyomi j   Togashi, Hitoshi h   more..


Author keywords

Chronic hepatitis B; HBV core related antigen; HBV DNA; Lamivudine resistance

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

EID: 33645967475     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01200.x     Document Type: Article
Times cited : (43)

References (29)
  • 1
    • 0026058540 scopus 로고
    • Inhibition of the replication of hepatitis B virus in vitro by 2′ 3′-dideoxy-3′-thiacytidine and related analogues
    • Doong S L, Tsai C H, Schinazi R F, Liotta D C, Cheng Y C. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991; 88: 8495-9.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 8495-8499
    • Doong, S.L.1    Tsai, C.H.2    Schinazi, R.F.3    Liotta, D.C.4    Cheng, Y.C.5
  • 2
    • 0028894411 scopus 로고
    • Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients
    • Benhamou Y, Dohin E, Lunel-Fabiani F, Poynard T, Huraox J M, Katlama C, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396-7.
    • (1995) Lancet , vol.345 , pp. 396-397
    • Benhamou, Y.1    Dohin, E.2    Lunel-Fabiani, F.3    Poynard, T.4    Huraox, J.M.5    Katlama, C.6
  • 5
    • 0032499913 scopus 로고    scopus 로고
    • A one-year trial of lamivudine for chronic hepatitis B
    • Asia Hepatitis Lamivudine Study Group
    • Lai C L, Chien R N, Leung N W, Chang T T, Guan R, Tai D I, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-8.
    • (1998) N Engl J Med , vol.339 , pp. 61-68
    • Lai, C.L.1    Chien, R.N.2    Leung, N.W.3    Chang, T.T.4    Guan, R.5    Tai, D.I.6
  • 6
    • 19544391413 scopus 로고    scopus 로고
    • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    • Liaw Y F, Sung J J, Chow W C, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.
    • (2004) N Engl J Med , vol.351 , pp. 1521-1531
    • Liaw, Y.F.1    Sung, J.J.2    Chow, W.C.3
  • 7
    • 23044471083 scopus 로고    scopus 로고
    • Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2,795 patients
    • Matsumoto A, Tanaka E, Rokuhara A, et al. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2,795 patients. Hepatol Res 2005; 32: 173-84.
    • (2005) Hepatol Res , vol.32 , pp. 173-184
    • Matsumoto, A.1    Tanaka, E.2    Rokuhara, A.3
  • 8
    • 0029815110 scopus 로고    scopus 로고
    • Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
    • Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711-3.
    • (1996) Hepatology , vol.24 , pp. 711-713
    • Ling, R.1    Mutimer, D.2    Ahmed, M.3
  • 9
    • 10744225554 scopus 로고    scopus 로고
    • Long-term safety of lamivudine treatment in patients with chronic hepatitis B
    • Lok A S, Lai C L, Leung N, Yao G B, Cui Z Y, Schiff E R, et al. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714-22.
    • (2003) Gastroenterology , vol.125 , pp. 1714-1722
    • Lok, A.S.1    Lai, C.L.2    Leung, N.3    Yao, G.B.4    Cui, Z.Y.5    Schiff, E.R.6
  • 11
    • 0032783679 scopus 로고    scopus 로고
    • Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
    • Liaw Y F, Chien R N, Yeh C T, Tsai S L, Chu C M. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567-72.
    • (1999) Hepatology , vol.30 , pp. 567-572
    • Liaw, Y.F.1    Chien, R.N.2    Yeh, C.T.3    Tsai, S.L.4    Chu, C.M.5
  • 12
    • 0042743964 scopus 로고    scopus 로고
    • Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan
    • Suzuki F, Tsubota A, Arase Y, Suzuki Y S, Akuta N, Hosaka T, et al. Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan. Intervirology 2003; 46: 182-9.
    • (2003) Intervirology , vol.46 , pp. 182-189
    • Suzuki, F.1    Tsubota, A.2    Arase, Y.3    Suzuki, Y.S.4    Akuta, N.5    Hosaka, T.6
  • 13
    • 0035212206 scopus 로고    scopus 로고
    • Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy
    • Zollner B, Schafer P, Feucht H H, Schroter M, Petersen J, Laufs R. Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy. J Med Virol 2001; 65: 659-63.
    • (2001) J Med Virol , vol.65 , pp. 659-663
    • Zollner, B.1    Schafer, P.2    Feucht, H.H.3    Schroter, M.4    Petersen, J.5    Laufs, R.6
  • 14
    • 0036159549 scopus 로고    scopus 로고
    • Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
    • Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Klyosawa K, et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol 2002; 40: 439-45.
    • (2002) J Clin Microbiol , vol.40 , pp. 439-445
    • Kimura, T.1    Rokuhara, A.2    Sakamoto, Y.3    Yagi, S.4    Tanaka, E.5    Klyosawa, K.6
  • 15
    • 0038045168 scopus 로고    scopus 로고
    • Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
    • Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, et al. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepatol 2003; 10: 324-30.
    • (2003) J Viral Hepatol , vol.10 , pp. 324-330
    • Rokuhara, A.1    Tanaka, E.2    Matsumoto, A.3    Kimura, T.4    Yamaura, T.5    Orii, K.6
  • 16
    • 0023926648 scopus 로고
    • Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein
    • Bruss V, Gerlich W H. Formation of transmembraneous hepatitis B e-antige0n by cotranslational in vitro processing of the viral precore protein. Virology 1988; 163: 268-75.
    • (1988) Virology , vol.163 , pp. 268-275
    • Bruss, V.1    Gerlich, W.H.2
  • 17
    • 0023943302 scopus 로고
    • Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm
    • Garcia P D, Ou J H, Rutter W J, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988; 106: 1093-104.
    • (1988) J Cell Biol , vol.106 , pp. 1093-1094
    • Garcia, P.D.1    Ou, J.H.2    Rutter, W.J.3    Walter, P.4
  • 18
    • 0030707941 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • Lee W M. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
    • (1997) N Engl J Med , vol.337 , pp. 1733-1745
    • Lee, W.M.1
  • 19
    • 0033045135 scopus 로고    scopus 로고
    • Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
    • Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999; 450: 66-71.
    • (1999) FEBS Lett , vol.450 , pp. 66-71
    • Mizokami, M.1    Nakano, T.2    Orito, E.3    Tanaka, Y.4    Sakugawa, H.5    Mukaide, M.6
  • 20
    • 0034056702 scopus 로고    scopus 로고
    • Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
    • Kobayashi S, Shimada K, Suzuki H, Tanikawa K, Sata M. Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif). Hepatol Res 2000; 17: 31-42.
    • (2000) Hepatol Res , vol.17 , pp. 31-42
    • Kobayashi, S.1    Shimada, K.2    Suzuki, H.3    Tanikawa, K.4    Sata, M.5
  • 22
    • 0025334855 scopus 로고
    • Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification
    • Summers J, Smith P M, Horwich A L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990; 64: 2819-24.
    • (1990) J Virol , vol.64 , pp. 2819-22924
    • Summers, J.1    Smith, P.M.2    Horwich, A.L.3
  • 23
    • 0023028191 scopus 로고
    • Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
    • Tuttleman J S, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47: 451-60.
    • (1986) Cell , vol.47 , pp. 451-460
    • Tuttleman, J.S.1    Pourcel, C.2    Summers, J.3
  • 24
    • 0030776176 scopus 로고    scopus 로고
    • Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
    • Moraleda G, Saputelli J, Aldrich C E, Averett D, Condreay L, Mason W S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 1997; 71: 9392-9.
    • (1997) J Virol , vol.71 , pp. 9392-9399
    • Moraleda, G.1    Saputelli, J.2    Aldrich, C.E.3    Averett, D.4    Condreay, L.5    Mason, W.S.6
  • 25
    • 2942532722 scopus 로고    scopus 로고
    • Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
    • Werle-Lapostolle B, Bowden S, Locarnini S, Worsthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126: 1750-8.
    • (2004) Gastroenterology , vol.126 , pp. 1750-1758
    • Werle-Lapostolle, B.1    Bowden, S.2    Locarnini, S.3    Worsthorn, K.4    Petersen, J.5    Lau, G.6
  • 26
    • 0034749753 scopus 로고    scopus 로고
    • Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis
    • Zhu Y, Yamamoto T, Cullen J, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 2001; 75: 311-22.
    • (2001) J Virol , vol.75 , pp. 311-322
    • Zhu, Y.1    Yamamoto, T.2    Cullen, J.3
  • 28
    • 0034802516 scopus 로고    scopus 로고
    • Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
    • Yuen M F, Sablon E, Hui C K, Yuan H J, Decraemer H, Lai C L. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 2001; 34: 785-91.
    • (2001) Hepatology , vol.34 , pp. 785-791
    • Yuen, M.F.1    Sablon, E.2    Hui, C.K.3    Yuan, H.J.4    Decraemer, H.5    Lai, C.L.6
  • 29
    • 0037353088 scopus 로고    scopus 로고
    • Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B
    • Mihm U, Sarrazin C, Herrmann E, Teuber G, von Wagner M, Kronea berger B, et al. Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B. Z Gastroenterol 2003; 41: 249-54.
    • (2003) Z Gastroenterol , vol.41 , pp. 249-254
    • Mihm, U.1    Sarrazin, C.2    Herrmann, E.3    Teuber, G.4    von Wagner, M.5    Kronea Berger, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.